Clinical Trials

Our Clinical Trials articles highlight top clinical trials, their results, and how patients can participate in them.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results

October 14, 2024

Learn about anitocabtagene autoleucel, a new CAR-T treatment for relapsed myeloma patients, showing promising results in Phase I trials.

What are Clinical Trials, and How May They Help Me?

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.

Can Yoga Help Myeloma Patients on Active Treatment?

August 29, 2024

Explore how yoga can improve physical and mental health for myeloma patients in a national clinical trial by the University of Arizona.

First R/R Myeloma Patient Treated with New BCMA-Directed Bispecific Antibody in Phase 3 Study

June 21, 2024

Learn about a new BCMA-directed bispecific antibody called ABBV-383, administered to relapsed/refractory myeloma patients in a clinical trial.

The Use of Bispecifics and CAR-T in Myeloma Treatment

May 21, 2024

The Use of Bispecifics And CAR-T In Myeloma Treatment

Ensuring Access to Myeloma Research, with Dr. Gurbakhash Kaur

May 07, 2024

Watch our interview with Dr. Kaur. She shared the comprehensive myeloma research program at UT Southwestern.

ORIC-533 : A New Small Molecule to Treat Multiple Myeloma

April 26, 2024

Learn about ORIC-533, a potential new oral treatment for myeloma. Understand how it works, early clinical trial results, and the future outlook for this drug.

How CAR-T Therapy is Changing the Treatment Landscape for Myeloma

April 18, 2024

Simmons Cancer Center leads Myeloma research with CAR-T, stem cells & more. Learn about GPRC5D targeting, Tregs, bispecific antibodies & upcoming trials.